Author

Francesco d’Amore

Observed name: d’Amore, Francesco

OpenAlex ID: A5149157103

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

2012 · d’Amore, Francesco, Leppa, Sirpa, et al. · GRO

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant

2011 · d’Amore, Francesco, da Silva, Maria Gomes, et al. · GRO

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

2010 · d’Amore, Francesco, da Silva, Maria Gomes, et al. · GRO

Works count: 3

Citation count:

H-index:

I10-index: